Juvenile Rheumatoid Arthritis Research Registry
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Juvenile rheumatoid arthritis (JRA) is the most common chronic inflammatory disease in children, and may be related to genetics. Having two siblings who both have JRA in one family is rare. The purpose of this registry is to collect patient information and blood samples from qualifying JRA siblings and their families. The goal of the registry is to further understanding of JRA as related to genetics.
| Condition |
|---|
|
Juvenile Rheumatoid Arthritis |
| Study Type: | Observational |
| Study Design: | Observational Model: Family-Based Time Perspective: Prospective |
| Official Title: | Research Registry for Juvenile Arthritis |
whole blood, serum, Pax gene
| Estimated Enrollment: | 200 |
| Study Start Date: | October 1994 |
| Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Sib Pairs
Two or more biological siblings affected with JIA.
|
Detailed Description:
JRA is the most common chronic inflammatory pediatric rheumatic disease. JRA may be related to a complex genetic trait. It is rare to have two or more affected siblings, or sibpairs, within one family. The JRA ASP (Affected Sibpair) Registry is a nationwide effort and will collect information and blood samples from JRA sibpairs and their families. Unaffected family members (e.g., mother, father, and unaffected children) are also invited to participate.
Patients and their families may enroll in the registry in one of two ways: patients may contact the registry directly, or they may be referred to the registry through their physician. Once the family has qualified to join the registry, the family will be asked to complete a questionnaire on the medical history of their JRA-affected members. Physicians of the JRA-affected members will be asked to complete questionnaires about their patients' conditions. Family members will also be invited to provide a one-time blood sample. Information collected through the registry will help researchers identify genes involved in JRA susceptibility.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
siblings affected with JIA
Inclusion Criteria for Patients and Their Families:
- At least two members of a family diagnosed with juvenile rheumatoid arthritis (JRA)
- Informed consent from the family indicating willingness to participate in the registry
Contacts and Locations| Contact: Sandy Kramer, CRC | 513-636-7692 | sandy.kramer@cchmc.org |
| United States, Ohio | |
| Cincinnati Children's Hospital Medical Center | Recruiting |
| Cincinnati, Ohio, United States, 45229-3039 | |
| Principal Investigator: David N. Glass, MD | |
| Principal Investigator: | David N. Glass, MD | Children's Hospital Medical Center, Cincinnati |
More Information
Additional Information:
Publications:
| Responsible Party: | David Glass, MD, Cincinnati Children's Hospital Medical Center |
| ClinicalTrials.gov Identifier: | NCT00090571 History of Changes |
| Other Study ID Numbers: | NIAMS-102, N01-AR-42218, NIAMS-102;N01-04-03 |
| Study First Received: | August 27, 2004 |
| Last Updated: | June 5, 2009 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS):
|
JRA ASPs Genomics |
Additional relevant MeSH terms:
|
Arthritis Arthritis, Rheumatoid Arthritis, Juvenile Rheumatoid Joint Diseases Musculoskeletal Diseases |
Rheumatic Diseases Connective Tissue Diseases Autoimmune Diseases Immune System Diseases |
ClinicalTrials.gov processed this record on May 16, 2013